View in EDS PDF Full Text

Immunogenicity of an adjuvanted broadly active influenza vaccine in immunocompromised and diverse populations.

Saved in:
Bibliographic Details
Title: Immunogenicity of an adjuvanted broadly active influenza vaccine in immunocompromised and diverse populations.
Authors: Hendy DA; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill North Carolina USA., Pena ES; Joint Department of Biomedical Engineering University of North Carolina at Chapel Hill and North Carolina State University Chapel Hill North Carolina USA., Ontiveros-Padilla L; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill North Carolina USA., Dixon TA; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill North Carolina USA., Middleton DD; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill North Carolina USA., Williamson GL; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill North Carolina USA., Lukesh NR; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill North Carolina USA., Simpson SR; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill North Carolina USA., Stiepel RT; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill North Carolina USA., Islam MJ; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill North Carolina USA., Carlock MA; Florida Research and Innovation Center Port St. Lucie Florida USA., Ross TM; Florida Research and Innovation Center Port St. Lucie Florida USA.; Center for Vaccines and Immunology University of Georgia Athens Georgia USA.; Department of Infectious Diseases University of Georgia Athens Georgia USA., Bachelder EM; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill North Carolina USA., Ainslie KM; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill North Carolina USA.; Joint Department of Biomedical Engineering University of North Carolina at Chapel Hill and North Carolina State University Chapel Hill North Carolina USA.; Department of Microbiology and Immunology, UNC School of Medicine University of North Carolina Chapel Hill North Carolina USA.
Source: Bioengineering & translational medicine [Bioeng Transl Med] 2023 Dec 08; Vol. 9 (2), pp. e10634. Date of Electronic Publication: 2023 Dec 08 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: John Wiley & Sons Inc Country of Publication: United States NLM ID: 101689146 Publication Model: eCollection Cited Medium: Print ISSN: 2380-6761 (Print) Linking ISSN: 23806761 NLM ISO Abbreviation: Bioeng Transl Med Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38435811
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Immunogenicity of an adjuvanted broadly active influenza vaccine in immunocompromised and diverse populations.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hendy+DA%22">Hendy DA</searchLink>; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill North Carolina USA.<br /><searchLink fieldCode="AU" term="%22Pena+ES%22">Pena ES</searchLink>; Joint Department of Biomedical Engineering University of North Carolina at Chapel Hill and North Carolina State University Chapel Hill North Carolina USA.<br /><searchLink fieldCode="AU" term="%22Ontiveros-Padilla+L%22">Ontiveros-Padilla L</searchLink>; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill North Carolina USA.<br /><searchLink fieldCode="AU" term="%22Dixon+TA%22">Dixon TA</searchLink>; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill North Carolina USA.<br /><searchLink fieldCode="AU" term="%22Middleton+DD%22">Middleton DD</searchLink>; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill North Carolina USA.<br /><searchLink fieldCode="AU" term="%22Williamson+GL%22">Williamson GL</searchLink>; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill North Carolina USA.<br /><searchLink fieldCode="AU" term="%22Lukesh+NR%22">Lukesh NR</searchLink>; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill North Carolina USA.<br /><searchLink fieldCode="AU" term="%22Simpson+SR%22">Simpson SR</searchLink>; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill North Carolina USA.<br /><searchLink fieldCode="AU" term="%22Stiepel+RT%22">Stiepel RT</searchLink>; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill North Carolina USA.<br /><searchLink fieldCode="AU" term="%22Islam+MJ%22">Islam MJ</searchLink>; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill North Carolina USA.<br /><searchLink fieldCode="AU" term="%22Carlock+MA%22">Carlock MA</searchLink>; Florida Research and Innovation Center Port St. Lucie Florida USA.<br /><searchLink fieldCode="AU" term="%22Ross+TM%22">Ross TM</searchLink>; Florida Research and Innovation Center Port St. Lucie Florida USA.; Center for Vaccines and Immunology University of Georgia Athens Georgia USA.; Department of Infectious Diseases University of Georgia Athens Georgia USA.<br /><searchLink fieldCode="AU" term="%22Bachelder+EM%22">Bachelder EM</searchLink>; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill North Carolina USA.<br /><searchLink fieldCode="AU" term="%22Ainslie+KM%22">Ainslie KM</searchLink>; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy University of North Carolina at Chapel Hill Chapel Hill North Carolina USA.; Joint Department of Biomedical Engineering University of North Carolina at Chapel Hill and North Carolina State University Chapel Hill North Carolina USA.; Department of Microbiology and Immunology, UNC School of Medicine University of North Carolina Chapel Hill North Carolina USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101689146%22">Bioengineering & translational medicine</searchLink> [Bioeng Transl Med] 2023 Dec 08; Vol. 9 (2), pp. e10634. <i>Date of Electronic Publication: </i>2023 Dec 08 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons+Inc%22">John Wiley & Sons Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101689146 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2380-6761 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223806761%22">23806761 </searchLink><i>NLM ISO Abbreviation: </i>Bioeng Transl Med <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38435811
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/btm2.10634
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e10634
    Titles:
      – TitleFull: Immunogenicity of an adjuvanted broadly active influenza vaccine in immunocompromised and diverse populations.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hendy DA
      – PersonEntity:
          Name:
            NameFull: Pena ES
      – PersonEntity:
          Name:
            NameFull: Ontiveros-Padilla L
      – PersonEntity:
          Name:
            NameFull: Dixon TA
      – PersonEntity:
          Name:
            NameFull: Middleton DD
      – PersonEntity:
          Name:
            NameFull: Williamson GL
      – PersonEntity:
          Name:
            NameFull: Lukesh NR
      – PersonEntity:
          Name:
            NameFull: Simpson SR
      – PersonEntity:
          Name:
            NameFull: Stiepel RT
      – PersonEntity:
          Name:
            NameFull: Islam MJ
      – PersonEntity:
          Name:
            NameFull: Carlock MA
      – PersonEntity:
          Name:
            NameFull: Ross TM
      – PersonEntity:
          Name:
            NameFull: Bachelder EM
      – PersonEntity:
          Name:
            NameFull: Ainslie KM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 08
              M: 12
              Text: 2023 Dec 08
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 2380-6761
          Numbering:
            – Type: volume
              Value: 9
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Bioengineering & translational medicine
              Type: main
ResultId 1